Novovax Available for 12 – year olds from 5th September 2022 On 28 July 2022 the Therapeutic Goods Administration (TGA) provisionally approved Nuvaxovid (Novavax) COVID-19 vaccine (Biocelect Pty Ltd/Novavax Inc) for use in adolescents aged 12-17 years. ATAGI has evaluated data on immunogenicity, efficacy, safety, and in international settings to [...]